Genelux Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GNLX | INO | TOVX | VIR | TVGN | NBP | |
|---|---|---|---|---|---|---|
| Market cap | 115.15M | 114.25M | 10.07M | 1.91B | 43.49M | 153.12M |
| P/E (TTM) | — | — | 0.3 | — | — | — |
| Forward P/E | -3.4 | -2.5 | -1.1 | -4.5 | — | -1.2 |
| Price/book | 7.0 | 20.8 | 0.8 | 1.9 | -1.5 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −51.24% | −53.44% | −51.11% | +99.66% | −81.03% | −75.91% |
| Today | −0.59% | −3.91% | +1.11% | −3.42% | −1.50% | −5.38% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GNLX news ›Analyzing CAMP4 Therapeutics (NASDAQ:CAMP) and Genelux (NASDAQ:GNLX)
Posted by Sarita Garza on Sep 29th, 2026 CAMP4 Therapeutics (NASDAQ:CAMP – Get Free Report) and Genelux (NASDAQ:GNLX – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
themarketsdaily.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.